Literature DB >> 24323564

Differential association of RANTES-403 and IL-1B-1464 polymorphisms on histological subtypes in male Korean patients with gastric cancer.

Juwon Kim1, Jong-Won Kim, Yoonjung Kim, Kyung-A Lee.   

Abstract

The aims of this study were to elucidate the association between RANTES-403 and an increased risk of gastric cancer in Korean males and to investigate the gene-gene interaction between IL-1B and RANTES. In total, 218 male patients with gastric cancer (114 diffuse types, 97 intestinal types, and 7 mixed types) and 377 male controls were included. RANTES-403 was genotyped, and age-adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were estimated by logistic regression. A multifactor dimensionality reduction (MDR) test with three-way split interval validation confirmed by likelihood ratio and permutation analysis was carried out. A significant increase in the risk of gastric cancer for the intestinal-type group was observed for IL-1B-1464G carriers (OR = 2.535; 95% CI = 1.121-5.732; P = 0.02) as well as for those with IL-1B-1464 CG (OR = 2.342; 95% CI = 0.998-5.500; P = 0.05) or IL-1B-1464 GG (OR = 2.819; 95% CI = 1.170-6.793; P = 0.02). For the RANTES-403 genotype, there was no significant difference in the risk of gastric cancer between the overall gastric cancer and the control groups. When further stratified according to histological types, RANTES-403A carriers (OR = 1.743; 95% CI = 1.086-2.798; P = 0.021) or heterozygotes (OR = 1.791; 95% CI = 1.092-2.935; P = 0.021) showed increased risk for developing diffuse-type gastric cancer. MDR revealed a three-way locus-locus interaction between RANTES-403AA, IL-1B-1464GG, and IL-1B-511CT for diffuse-type gastric cancer in Korean males. We demonstrated that RANTES-403 was significantly associated with the risk of developing diffuse-type gastric cancer in men and found a possible gene-gene interaction between RANTES and IL-1B polymorphisms in gastric cancer carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323564     DOI: 10.1007/s13277-013-1498-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

1.  Estradiol and interleukin-1beta exert a synergistic stimulatory effect on the expression of the chemokine regulated upon activation, normal T cell expressed, and secreted in endometriotic cells.

Authors:  Ali Akoum; André Lemay; Rodolphe Maheux
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines.

Authors:  R P Negus; G W Stamp; J Hadley; F R Balkwill
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES.

Authors:  R G Nickel; V Casolaro; U Wahn; K Beyer; K C Barnes; B S Plunkett; L R Freidhoff; C Sengler; J R Plitt; R P Schleimer; L Caraballo; R P Naidu; P N Levett; T H Beaty; S K Huang
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

4.  The RANTES gene promoter polymorphisms are associated with the risk of atherothrombotic cerebral infarction in Northern Han Chinese.

Authors:  Xue Qin; Zhiyi He; Dongxue Zhao; Lei Li; Liying Yuan
Journal:  Clin Chim Acta       Date:  2011-03-03       Impact factor: 3.786

5.  Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer.

Authors:  Young-Woon Chang; Jae-Young Jang; Nam-Hoon Kim; Jae Won Lee; Hyo Jung Lee; Woon Won Jung; Seok-Ho Dong; Hyo-Jong Kim; Byung-Ho Kim; Joung-Il Lee; Rin Chang
Journal:  Int J Cancer       Date:  2005-04-10       Impact factor: 7.396

6.  Polymorphisms in interleukin-1B (IL-1B) and interleukin 1 receptor antagonist (IL-1RN) genes associate with gastric cancer risk in the Chinese population.

Authors:  Bang-Shun He; Yu-Qin Pan; Yong-Fei Xu; Chan Zhu; Li-Li Qu; Shu-Kui Wang
Journal:  Dig Dis Sci       Date:  2011-01-18       Impact factor: 3.199

7.  Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system.

Authors:  Sarah Frise; Nancy Kreiger; Steven Gallinger; George Tomlinson; Michelle Cotterchio
Journal:  Ann Epidemiol       Date:  2006-07-13       Impact factor: 3.797

8.  Prognostic significance of expression of CCL5/RANTES receptors in patients with gastric cancer.

Authors:  Hidekazu Sugasawa; Takashi Ichikura; Hironori Tsujimoto; Manabu Kinoshita; Daisaku Morita; Satoshi Ono; Kentaro Chochi; Hitoshi Tsuda; Shuhji Seki; Hidetaka Mochizuki
Journal:  J Surg Oncol       Date:  2008-04-01       Impact factor: 3.454

9.  Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination.

Authors:  Hidekazu Sugasawa; Takashi Ichikura; Manabu Kinoshita; Satoshi Ono; Takashi Majima; Hironori Tsujimoto; Kentaro Chochi; Sadayuki Hiroi; Eiji Takayama; Daizoh Saitoh; Shuhji Seki; Hidetaka Mochizuki
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

10.  A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk.

Authors:  Francesco Gianfagna; Emma De Feo; Cornelia M van Duijn; Gualtiero Ricciardi; Stefania Boccia
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

View more
  3 in total

1.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

Review 2.  Ethnic differences in gastric cancer genetic susceptibility: allele flips of interleukin gene.

Authors:  Juwon Kim; Yoonjung Kim; Kyung-A Lee
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

3.  Complement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in chinese population.

Authors:  Lina Zhao; Zhi Zhang; Jia Lin; Lei Cao; Bing He; Sugui Han; Xuemei Zhang
Journal:  J Cancer       Date:  2015-04-05       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.